Long-term survival after intraperitoneal chemotherapy with paclitaxel-cisplatin for recurrent primary peritoneal cancer resistant to multiple lines of intravenous chemotherapy

• Prif Awduron: Hyejeong Hue (Awdur), Kidong Kim (Awdur), HyoJin Kim (Awdur), Dong Hoon Suh (Awdur), Jae Hong No (Awdur), Yong Beom Kim (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: Korean Society of Obstetrics and Gynecology, 2019-07-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

The long-term survival of heavily pretreated patients with primary peritoneal cancer (PPC) is uncommon. Here, we report on a patient with PPC refractory to multiple lines of intravenous chemotherapy, namely, a combined regimen of paclitaxel and carboplatin, and single regimens of topotecan, docetaxe...